With a growing Transactions Team that is establishing itself as one of the leading independent practices in the market, Van Bael & Bellis (VBB), a Brussels-based international law firm, is pleased to announce the arrival of leading corporate M&A partner Caroline Daout alongside senior associates Virginie Lescot and Cedric Hauben as well as associates Jens Westerwoudt and Charles-Antoine du Bus.
Earlier this month, the European Federation of Pharmaceutical Industries and Associations, EFPIA, published a study prepared by the strategic market access consultancy Dolon (the Study) providing for a data-based impact assessment of the proposed Pharmaceutical Package (the Proposal) of the European Commission
Economic Inspection identified 9,942 breaches by webstores On Friday, 24 November 2023 consumers around the world scavenge online marketplaces and webstores to find the best Black Friday deals
The Belgian Official Journal of 14 November 2023 contains a Royal Decree of 9 November 2023 (the RD - attached) that limits the scope of authorised prescriptions for GLP-1 analogues to the following categories of patients:
On 17 November 2023, the UK Competition and Markets Authority published a statement clarifying that specific types of collaborative conduct involving competing medicine suppliers which work on bringing a combination therapy to market by supplying that therapy at a “cost effective price” to the National Health Service
The October 2023 issue of our Belgian Business Law newsletter reporting on the latest developments in a range of areas, including competition, data protection, intellectual property and litigation.
The EU Deforestation Regulation introduces rigorous new deforestation due diligence requirements and other compliance obligations in respect of seven commodities.
The trend towards closer competition scrutiny of small acquisitions, even if these transactions do not satisfy the financial thresholds provided for by EU merger control rules or relevant national legislation, yesterday gained further traction in Belgium and the Netherlands. The life sciences industry will take note.
On 12 October 2023, the UK Extension to the EU-U.S. Data Privacy Framework (UK Extension) – also known as the UK-US Data Bridge – took effect, paving the way for transatlantic personal data transfers from the United Kingdom (UK) to the United States (US). The UK Extension permits the flow of personal data from the UK to the US without the need for further safeguards.
